{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:46:26Z","timestamp":1761659186278,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ajg.2021.03.001","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:21:55Z","timestamp":1617384115000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-8666","authenticated-orcid":false,"given":"Arwa","family":"Kamhawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab Nabil","family":"Ahmed Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salwa Elsayed","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Eletreby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan El","family":"Garem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El Kassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2021.03.001_b0005","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis,2016-2021.http:\/\/apps.who.int\/iris\/bitstream\/10665\/246177\/1\/who-hiv-2016.06-eng.pdf?ua=1."},{"key":"10.1016\/j.ajg.2021.03.001_b0010","unstructured":"Ministry of Health and Population [Egypt], El-Zanaty and Associates [Egypt] & and ICF International. Egypt Health Issues Survey 2015. (Cairo, Egypt and Rockville, Maryland, USA: Ministry of Health and Population and ICF International, 2015)."},{"issue":"34","key":"10.1016\/j.ajg.2021.03.001_b0015","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2021.03.001_b0020","unstructured":"MurphyK. Centre for diseaseanalysisfoundation,2018. https:\/\/cdafound.org\/just-12-countries-worldwide-on-track-to-eliminate-hepatitis-c-infection-by-2030-with-united-kingdom-italy-and-spain-among-those-joining-the-list\/?platform=hootsuite"},{"issue":"4","key":"10.1016\/j.ajg.2021.03.001_b0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jvh.12668","article-title":"National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care","volume":"24","author":"El-Akel","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ajg.2021.03.001_b0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/17474124.2018.1476137","article-title":"An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens","volume":"12","author":"El Kassas","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol."},{"issue":"3","key":"10.1016\/j.ajg.2021.03.001_b0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/apt.14428","article-title":"Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18378 patients in Egypt","volume":"47","author":"Omar","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajg.2021.03.001_b0040","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S0618-8278(19)30254-3","article-title":"LBP-08-The world\u2019s largest hepatitis C screening program in Egypt","volume":"70","author":"Abdel-Razek","year":"2019","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.ajg.2021.03.001_b0045","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and treatment program to eliminate hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ajg.2021.03.001_b0050","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jiph.2020.05.008","article-title":"Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: enablers and obstacles","volume":"13","author":"Shousha","year":"2020","journal-title":"J Infect Public Health."},{"issue":"7","key":"10.1016\/j.ajg.2021.03.001_b0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14787210.2020.1758065","article-title":"Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt","volume":"18","author":"Esmat","year":"2020","journal-title":"Expert Rev Anti Infect Ther."},{"issue":"6","key":"10.1016\/j.ajg.2021.03.001_b0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cld.868","article-title":"Hepatitis C Virus in Egypt: Interim Report from the world's largest national program","volume":"14","author":"Abdel-Razek","year":"2020","journal-title":"Clin Liver Dis (Hoboken)."},{"issue":"5","key":"10.1016\/j.ajg.2021.03.001_b0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.2004.057281","article-title":"Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection","volume":"54","author":"Castillo","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ajg.2021.03.001_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14218\/JCTH.2017.00053","article-title":"Occult hepatitis C virus infection: a review","volume":"6","author":"Austria","year":"2018","journal-title":"J Clin Transl Hepatol"},{"issue":"23","key":"10.1016\/j.ajg.2021.03.001_b0075","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3748\/wjg.v18.i23.2887","article-title":"New perspectives in occult hepatitis C virus infection","volume":"18","author":"Carre\u00f1o","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"14","key":"10.1016\/j.ajg.2021.03.001_b0080","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1128\/JVI.02750-06","article-title":"Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C","volume":"81","author":"Bartolom\u00e9","year":"2007","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.ajg.2021.03.001_b0085","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jmv.21866","article-title":"Diagnosis of occult hepatitis C without the need for a liver biopsy","volume":"82","author":"Castillo","year":"2010","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.ajg.2021.03.001_b0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1743-422X-10-346","article-title":"Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+ (2013)","volume":"26","author":"Pawe\u0142czyk","year":"2013","journal-title":"Virol J."},{"key":"10.1016\/j.ajg.2021.03.001_b0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ebiom.2019.07.043","article-title":"Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality","volume":"46","author":"Wang","year":"2019","journal-title":"EBiomedicine"},{"issue":"10","key":"10.1016\/j.ajg.2021.03.001_b0100","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/MEG.0000000000001459","article-title":"Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction","volume":"31","author":"Hanafy","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2021.03.001_b0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0000000000001316","article-title":"Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients","volume":"31","author":"Lybeck","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.ajg.2021.03.001_b0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2893.2011.01464.x","article-title":"Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients","volume":"18","author":"Roque-Cu\u00e9llar","year":"2011","journal-title":"J Viral Hepat"},{"issue":"7","key":"10.1016\/j.ajg.2021.03.001_b0115","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/jmv.21483","article-title":"Hepatitis C virus infection in the family setting of patients with occult hepatitis C","volume":"81","author":"Castillo","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajg.2021.03.001_b0120","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"B\u00f6yum","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"6","key":"10.1016\/j.ajg.2021.03.001_b0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MAJ.0b013e3181ec435e","article-title":"Detection of HCV RNA in the peripheral blood mononuclear cells of serum HCV RNA-negative Egyptian patients under interferon treatment","volume":"340","author":"Zayed","year":"2010","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.ajg.2021.03.001_b0130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ajg.2021.03.001_b0135","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/hep.22184","article-title":"Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia","volume":"47","author":"Bernardin","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajg.2021.03.001_b0140","first-page":"1","article-title":"Hepatitis C virus RNA strands detection in peripheral blood mononuclear cells legitimizes virus eradication in negative serum PCR na\u00efve and post-treatment patients","volume":"5","author":"Abd Alla","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2021.03.001_b0145","first-page":"237","article-title":"Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents","volume":"26","author":"Yousif","year":"2018","journal-title":"Infez Med"},{"issue":"12","key":"10.1016\/j.ajg.2021.03.001_b0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IDR.S181638","article-title":"Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir\/daclatasvir therapy: a multi-center study","volume":"12","author":"Mekky","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"14","key":"10.1016\/j.ajg.2021.03.001_b0155","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1128\/JVI.00629-11","article-title":"Host-based ribavirin resistance influences hepatitis C virus replication and treatment response","volume":"85","author":"Ibarra","year":"2011","journal-title":"J Virol."},{"issue":"2","key":"10.1016\/j.ajg.2021.03.001_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.14218\/JCTH.2017.00077","article-title":"HCV therapy follow-up fractionation (CTF2) by intra-PBMC nested RNA PCR recognizes early virologic response and relapse","volume":"6","author":"Abd Alla","year":"2018","journal-title":"J Clin Transl Hepatol"},{"issue":"10","key":"10.1016\/j.ajg.2021.03.001_b0165","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/jvh.12917","article-title":"Shortened therapy of eight weeks with paritaprevir\/ritonavir\/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection","volume":"25","author":"Martinello","year":"2018","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.ajg.2021.03.001_b0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jgh.14815","article-title":"Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir\/asunaprevir","volume":"35","author":"Huang","year":"2020","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.ajg.2021.03.001_b0175","unstructured":"Food and drug administration. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-treatment-adults-and-children-all-genotypes-hepatitis-c-and-compensated-cirrhosis"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:42:13Z","timestamp":1761658933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197921000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1687197921000034"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2021.03.001","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2021.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}